Anthropic Inc. (ticker: ANTP) closes its first Nasdaq trading day above the IPO issue price (IPO October 2026, confirmed by Bloomberg or Reuters by November 1, 2026)
Miss
✦ AI-generated prediction
Published on 3. October 2026
·
Predicted for 31. October 2026
·
Based on: Speculative
Anthropic is planning its Nasdaq debut for October 2026 — ahead of the US midterms on November 3. The latest private valuation (Series H, May 2026) was $965 billion; the IPO target valuation is approximately $2 trillion. Roadshow start: mid-October; lead underwriters: Morgan Stanley, Goldman Sachs, JPMorgan. The confidential S-1 filing was made on June 1, 2026. Historically, highly anticipated AI/tech mega-IPOs close with a positive first-day return in ~75–80% of cases. Counter-probability: ~20% delay risk beyond October 31 and ~15–18% below-issue-price risk. No direct Polymarket market available; calibration based solely on historical IPO data and market conditions.
Data basis for this prediction
- TheNextWeb: Anthropic wählt Nasdaq für Oktober-IPO (Oktober 2026)
- AIBusinessWeekly: Privatbewertung $965 Mrd. Series H Mai 2026; IPO-Ziel ~$2 Bio.
- Startuphub.ai: Roadshow Mitte Oktober; S-1 confidential 1.6.2026; Underwriter MS/GS/JPM
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Miss
Die Vorhersage traf nicht ein. Anthropic reichte am 26. Oktober 2026 seinen öffentlichen S-1 bei der SEC ein (Ticker: ANT, nicht ANTP), doch der erste Handelstag ist frühestens für den 16. November 2026 geplant – also deutlich nach der Deadline 1. November 2026 und auch nach den US-Midterms am 3. November. Es gab somit bis zum Stichtag weder einen Ausgabepreis noch einen ersten Handelstag, der hätte über- oder unterschritten werden können. Der IPO wurde nicht in Oktober 2026 vollzogen, sondern nur die S-1-Einreichung erfolgte. Quellen: Bloomberg (https://www.bloomberg.com/news/articles/2026-10-26/anthropic-ipo-s-1-filing-offers-first-look-at-claude-maker-s-finances), Yahoo Finance (https://finance.yahoo.com/markets/article/when-is-the-anthropic-ipo-the-stock-could-start-trading-as-soon-as-nov-16-132727631.html), CNBC (https://www.cnbc.com/2026/10/26/anthropic-ipo-live-updates-ai-s-1-filing.html).
💻 Technology
✦ AI
Applied Materials has beaten the EPS consensus in all four of its last reported quarters, with an average earnings surprise of +3.5%. The company's own Q4 guidance is $3.82–$4.22 per share; consensus at $4.06 sits near the midpoint, reflecting classic conservative management framing. Revenue is estimated at $10.30B (+51% YoY) — TSMC and Samsung have not pulled back H2 2026 capex plans. No Polymarket market directly available; a 100% beat streak over 4 quarters with a positive guidance range implies 70–75% probability. Risk: supply chain delays or expanded US export controls on advanced chips could force a Q5 inventory build.
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.